NFCR Writer David Perry, Author at NFCR

NFCR Writer David Perry

Kidney Cancer Detection Advances

About 73,820 new cases of kidney cancer are forecast to be diagnosed among Americans in 2019, and nearly 14,770 can be expected to die from the disease. Cancer of the kidneys, like any cancer, is most curable at an early stage. However, the majority of early-stage tumors do not present…...

Read more

Zhen-Yi Wang & Zhu Chen: Quite a Combination

There was a time when if you were diagnosed with acute promyelocytic leukemia, or APL, the prognosis was grim. First discovered in 1957, APL is a form of acute myeloid leukemia, where immature white blood cells called promyelocytes accumulate in the bone marrow. The overgrowth of promyelocytes leads to a…...

Read more

Carlo Croce: It’s All About (Trans)Location

“It was a great pleasure because it is so important,” recalls Carlo Croce, M.D., of his 2008 win of the National Foundation for Cancer Research’s Szent-Györgyi Prize for Progress in Cancer Research. “The committee is very selective, and they really want to choose outstanding people who really have made a…...

Read more

Metastasis Suppressor Genes

“It’s what I consider the most interesting science in the world,” says NFCR Fellow Danny Welch, Ph.D. He is alluding to his work discovering the presence of metastasis-suppressing genes in human DNA. Welch, the Hall Family Professor of Molecular Medicine, a professor of cancer biology and an associate director of…...

Read more

Cancer Genomics Research: A Young and Exciting Field

Genomics is an interdisciplinary field of science focusing on the structure, function, evolution, mapping and editing of genomes, which itself is a specific organism’s complete set of DNA, including all of its genes. While DNA was first isolated in 1869, and its structure identified in 1953, genomes were not first…...

Read more

Alex Matter: Making Targeted Therapy a Reality

“I was attracted, even as a youngster, by infectious diseases and cancer,” recalls Alex Matter, M.D. That young boy would pursue these passions and, in adulthood, emerge as a leading global authority in the disease field. Now the CEO of the Agency for Science, Technology and Research, or A*STAR, the…...

Read more

An Analytical Tool Like Few Others

When he passed away in April 2004, Dr. Csaba Horváth had more than a few laurels upon which he could eternally rest. Though most famously, Horváth was the first scientist to design, construct and show molecular separations using high-performance liquid chromatography (HPLC). The analytical technology has since served as foundation…...

Read more

Cancer and Genomics: A Primer

In 2017, genetic researchers in the United Kingdom introduced a powerful new mechanical tool in the growing field of genomics which may guide the way to new cancer treatments. The high-tech genome sequencer, the Illumina NovaSeqTM 6000, was unveiled at The Institute of Cancer Research (the ICR) in London. “It…...

Read more

Breast Cancer Linked to Bone Marrow Cells

“Our study shows that the recruitment of bone marrow-derived fibroblasts is important for promoting tumor growth, likely by enhancing blood vessel formation,” says Dr. Neta Erez of the Sackler School of Medicine at Tel Aviv University, discussing a recent discovery finding that breast cancer can “recruit” stromal cells originally formed…...

Read more

“Pink Drink” to Aid Brain Tumor Treatment

Approved in June 2017 by the U.S. Food and Drug Administration and launched commercially in-country in October 2018, 5-Aminolevulinic Acid (also known as 5-ALA, and composed of aminolevulinic acid hydrochloride) is an optical imaging agent for use in patients with high-grade gliomas. Nicknamed the “pink drink,” 5-ALA is a surgical…...

Read more